Webinars in Chinese! – Everything you need to know about HoloMonitor

Languages should be the tool to facilitate your research instead of creating barriers. To help our customers who speak different languages, PHI and our local partner in China, Bio-Sun, held two webinars in Chinese to explain everything you need to know about HoloMonitor.

In these two webinars, our application specialist, Haoran Yu, presents you with how HoloMonitor can help you with your daily research. During these two webinars, you will learn about:

  • Digital holography technology
  • Benefits of label-free imaging
  • Label-free live cell assays and their output
  • Recent publications about HoloMonitor in cancer research, stem cell study, in vitro drug discovery, 3D cell culturing and regenerative medicine

Scan the QR code and follow us on WeChat to receive our latest news and product information in Chinese!

WeChat QR code

Scan the QR code to follow us!

With WeChat Official Account, you can:

  • Find the latest HoloMonitor articles in Chinese
  • Chat with us
  • Request support directly from your phone
  • And much, much more!
cell banner

Don’t forget you can also:

Contact us directly
— in Chinese or English

Haoran Yu

Haoran Yu, application specialist (Chinese-speaking)

“Simply fill out the contact form, and our PHI team will contact you with more information about the HoloMonitor system and ways we can support you in your research.”

Contact our local partner in China

You can also contact Bio-sun, our local partner in China, with your questions!

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2